21
TÍTULO: Human disposition, metabolism and excretion of etamicastat, a reversible, peripherally selective dopamine beta-hydroxylase inhibitor. Etamicastat metabolism and excretion  Full Text
AUTORES: Ana I Loureiro; Jose F Rocha; Carlos Fernandes Lopes; Teresa Nunes; Lyndon C Wright; Luis Almeida; Patricio Soares da Silva ;
PUBLICAÇÃO: 2014, FONTE: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 77, NÚMERO: 6
INDEXADO EM: Scopus WOS CrossRef: 7
NO MEU: ORCID
23
TÍTULO: Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Integrated analysis of pooled data from double-blind phase III clinical studies. ESL in the Treatment of Focal-Onset Seizures   Full Text
AUTORES: Gil Nagel, A; Elger, C; Ben Menachem, E; Halasz, P; Lopes Lima, J; Gabbai, AA; Nunes, T; Falcao, A ; Almeida, L; Soares da Silva, P ;
PUBLICAÇÃO: 2013, FONTE: EPILEPSIA, VOLUME: 54, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef: 72
NO MEU: ORCID
30
TÍTULO: Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel COMT inhibitor, during the first administration to healthy male subjects  Full Text
AUTORES: Nunes, T; F Rocha; Pinto, R ; Machado, R; Wright, L; Falcao, A; Almeida, L; Soares da Silva, P ;
PUBLICAÇÃO: 2012, FONTE: 16th Congress of the European-Federation-of-Neurological-Societies (EFNS) in EUROPEAN JOURNAL OF NEUROLOGY, VOLUME: 19
INDEXADO EM: WOS
NO MEU: ORCID
Página 3 de 10. Total de resultados: 92.